SRAD earnings
Analysis, not adviceNext print
2026-08-04
cons 0.06 EPS / 0.44B rev
The desk's graded verdict
intactgraded 2026-05-24
PASSFY26 full-year guidance reaffirmed
“we reaffirming of our '26 full year financial outlook. This reflects the great confidence we have in our business model”
PASSNo partner terminations or contract renegotiations reported
“we reject the unfounded and misinformed allegations... we continue to conduct our business in a manner consistent with the highest standards”
Educational analysis, not a personalised recommendation. See all covered names on the earnings calendar · part of our public track record.